Home Newsfeeds Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $165

Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $165

Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from $172 to $165.

byBenzinga Newsdesk

October 11, 2022

1 minute read

Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from $172 to $165.

Tesla, Crinetics Pharmaceuticals And Other Big Stocks Moving Higher In Monday’s Pre-Market Session

By Lisa Levin

September 11, 5:35 AM

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.

BGNE

Enbridge, Funko And 3 Stocks To Watch Heading Into Friday

By Avi Kapoor

May 10, 3:01 AM

With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor…

ARRY

Analyst Ratings

Analyst Expectations for Payoneer Global’s Future

By Benzinga Insights

July 11, 9:00 AM

Payoneer Global (NASDAQ:PAYO) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

PAYO

Fluor And SunCoke Energy Renew Maintenance And Capital Project Contract For 7-Years

By Benzinga Newsdesk

April 29, 4:09 PM

Fluor Corporation (NYSE:FLR) and longstanding client SunCoke Energy, Inc. (SunCoke) have announced a seven-year contract extension at its five coke plants in the United States. Fluor will recognize the undisclosed value

FLR

Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $165

Related Posts

Tesla, Crinetics Pharmaceuticals And Other Big Stocks Moving Higher In Monday’s Pre-Market Session

Enbridge, Funko And 3 Stocks To Watch Heading Into Friday

Analyst Expectations for Payoneer Global’s Future

Fluor And SunCoke Energy Renew Maintenance And Capital Project Contract For 7-Years